Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery

<div>Drug release profile of <i>α</i>-mangostin formulated as Tf-LPHN and Ctrl-LPHN or as a free drug in phosphate buffer saline containing 0.5% Tween 20 at pH 7.4 over 72 hours (<i>n</i> = 3).</div>

The Scientific World Journal

fig3

Figure 3

Figure 3: Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery 

Figure 3 | Alpha-Mangostin-Loaded Transferrin-Conjugated Lipid-Polymer Hybrid Nanoparticles: Development and Characterization for Tumor-Targeted Delivery 